文献速递脑血管病

遗传决定的血压、降压药类别与卒中亚型风险

Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes.
PubMed 文献 · Neurology · 2020-07-01

该研究采用孟德尔随机化方法,基于757,601名个体的GWAS数据,探讨遗传决定的血压及不同降压药靶点基因变异与各卒中亚型的关联。结果支持高血压对所有主要卒中亚型(除脑叶出血外)的因果作用,并发现钙通道阻滞剂与任何卒中、缺血性卒中及小血管卒中风险降低相关。

要点

  • 遗传决定的收缩压和舒张压升高与任何卒中、缺血性卒中及脑出血风险增加相关。
  • 钙通道阻滞剂遗传代理与任何卒中及缺血性卒中风险降低相关,β受体阻滞剂无此关联。
  • 钙通道阻滞剂对小血管卒中和白质高信号放射学表型关联尤为显著。

核心结论

  • 高血压对所有主要卒中亚型(除脑叶出血外)具有因果作用。
  • 不同降压药类别对卒中亚型的效果存在差异,钙通道阻滞剂是预防脑小血管病表现的有前景策略。

研究设计与样本

  • 采用两样本孟德尔随机化设计,从757,601名个体的全基因组关联研究中选取与收缩压、舒张压及降压药靶点基因相关的遗传变异。

主要发现

  • 遗传决定的血压升高与任何卒中、缺血性卒中及脑出血风险增加相关。
  • 遗传决定的血压与所有缺血性卒中亚型相关,其中大动脉卒中小血管卒中风险高于心源性卒中。
  • 遗传决定的血压与深部脑出血相关,但与脑叶出血无关。
  • 钙通道阻滞剂遗传代理与任何卒中及缺血性卒中风险降低相关,β受体阻滞剂无此关联。
  • 钙通道阻滞剂遗传代理与小血管卒中及白质高信号放射学表型关联尤为显著。

临床怎么用

  • 对于卒中预防,尤其小血管卒中及脑小血管病影像表现者,可考虑优先选用钙通道阻滞剂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We employed Mendelian randomization to explore whether the effects of blood pressure (BP) and BP-lowering through different antihypertensive drug classes on stroke risk vary by stroke etiology. METHODS: We selected genetic variants associated with systolic and diastolic BP and BP-lowering variants in genes encoding antihypertensive drug targets from genome-wide association studies (GWAS) on 757,601 individuals. Applying 2-sample Mendelian randomization, we examined associations with any stroke (67,162 cases; 454,450 controls), ischemic stroke and its subtypes (large artery, cardioembolic, small vessel stroke), intracerebral hemorrhage (ICH, deep and lobar), and the related small vessel disease phenotype of white matter hyperintensities (WMH). RESULTS: Genetic predisposition to higher systolic and diastolic BP was associated with higher risk of any stroke, ischemic stroke, and ICH. We found associations between genetically determined BP and all ischemic stroke subtypes with a higher risk of large artery and small vessel stroke compared to cardioembolic stroke, as well as associations with deep, but not lobar ICH. Genetic proxies for calcium channel blockers, but not β-blockers, were associated with lower risk of any stroke and ischemic stroke. Proxies for calcium channel blockers showed particularly strong associations with small vessel stroke and the related radiologic phenotype of WMH. CONCLUSIONS: This study supports a causal role of hypertension in all major stroke subtypes except lobar ICH. We find differences in the effects of BP and BP-lowering through antihypertensive drug classes between stroke subtypes and identify calcium channel blockade as a promising strategy for preventing manifestations of cerebral small vessel disease.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Georgakis MK, Gill D, Webb AJS, et al. Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes. Neurology. 2020. PMID: 32611631. doi:10.1212/WNL.0000000000009814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。